141 related articles for article (PubMed ID: 31284000)
21. Fenofibrate attenuates nicotine-induced vascular endothelial dysfunction in the rat.
Chakkarwar VA
Vascul Pharmacol; 2011; 55(5-6):163-8. PubMed ID: 21864717
[TBL] [Abstract][Full Text] [Related]
22. Roles and mechanisms of human immunodeficiency virus protease inhibitor ritonavir and other anti-human immunodeficiency virus drugs in endothelial dysfunction of porcine pulmonary arteries and human pulmonary artery endothelial cells.
Wang X; Chai H; Lin PH; Yao Q; Chen C
Am J Pathol; 2009 Mar; 174(3):771-81. PubMed ID: 19218343
[TBL] [Abstract][Full Text] [Related]
23. Endothelial dysfunction and compromised eNOS/Akt signaling in the thoracic aorta during the progression of Marfan syndrome.
Chung AW; Au Yeung K; Cortes SF; Sandor GG; Judge DP; Dietz HC; van Breemen C
Br J Pharmacol; 2007 Apr; 150(8):1075-83. PubMed ID: 17339838
[TBL] [Abstract][Full Text] [Related]
24. Telmisartan attenuates monocrotaline-induced pulmonary artery endothelial dysfunction through a PPAR gamma-dependent PI3K/Akt/eNOS pathway.
Li H; Lu W; Cai WW; Wang PJ; Zhang N; Yu CP; Wang DL; Liu BC; Sun W
Pulm Pharmacol Ther; 2014 Jun; 28(1):17-24. PubMed ID: 24269521
[TBL] [Abstract][Full Text] [Related]
25. The dual PPARα/γ agonist aleglitazar increases the number and function of endothelial progenitor cells: implications for vascular function and atherogenesis.
Werner CM; Schirmer SH; Gensch C; Pavlickova V; Pöss J; Wright MB; Böhm M; Laufs U
Br J Pharmacol; 2014 May; 171(10):2685-703. PubMed ID: 24467636
[TBL] [Abstract][Full Text] [Related]
26. Omega 3 Polyunsaturated Fatty Acids Improve Endothelial Dysfunction in Chronic Renal Failure: Role of eNOS Activation and of Oxidative Stress.
Zanetti M; Gortan Cappellari G; Barbetta D; Semolic A; Barazzoni R
Nutrients; 2017 Aug; 9(8):. PubMed ID: 28820443
[TBL] [Abstract][Full Text] [Related]
27. Metformin protects endothelial function in diet-induced obese mice by inhibition of endoplasmic reticulum stress through 5' adenosine monophosphate-activated protein kinase-peroxisome proliferator-activated receptor δ pathway.
Cheang WS; Tian XY; Wong WT; Lau CW; Lee SS; Chen ZY; Yao X; Wang N; Huang Y
Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):830-6. PubMed ID: 24482374
[TBL] [Abstract][Full Text] [Related]
28. Fenofibrate and pioglitazone do not ameliorate the altered vascular reactivity in aorta of isoproterenol-treated rats.
Fukuda LE; Davel AP; Verissimo-Filho S; Lopes LR; Cachofeiro V; Lahera V; Rossoni LV
J Cardiovasc Pharmacol; 2008 Nov; 52(5):413-21. PubMed ID: 19033820
[TBL] [Abstract][Full Text] [Related]
29. Aliskiren improves endothelium-dependent relaxation of thoracic aorta by activating PI3K/Akt/eNOS signal pathway in SHR.
Gu Y; Tang X; Xie L; Meng G; Ji Y
Clin Exp Pharmacol Physiol; 2016 Apr; 43(4):450-8. PubMed ID: 26804705
[TBL] [Abstract][Full Text] [Related]
30. Vascular Protective Effects of Xanthotoxin and Its Action Mechanism in Rat Aorta and Human Vascular Endothelial Cells.
Cao LH; Lee HS; Quan ZS; Lee YJ; Jin Y
J Vasc Res; 2020; 57(6):313-324. PubMed ID: 32726786
[TBL] [Abstract][Full Text] [Related]
31. Diclofenac but not celecoxib improves endothelial function in rheumatoid arthritis: A study in adjuvant-induced arthritis.
Verhoeven F; Totoson P; Marie C; Prigent-Tessier A; Wendling D; Tournier-Nappey M; Prati C; Demougeot C
Atherosclerosis; 2017 Nov; 266():136-144. PubMed ID: 29024866
[TBL] [Abstract][Full Text] [Related]
32. Imperatorin alleviates metabolic and vascular alterations in high-fat/high-fructose diet-fed rats by modulating adiponectin receptor 1, eNOS, and p47
Bunbupha S; Prasarttong P; Poasakate A; Maneesai P; Pakdeechote P
Eur J Pharmacol; 2021 May; 899():174010. PubMed ID: 33711309
[TBL] [Abstract][Full Text] [Related]
33. Homocysteine impaired endothelial function through compromised vascular endothelial growth factor/Akt/endothelial nitric oxide synthase signalling.
Yan TT; Li Q; Zhang XH; Wu WK; Sun J; Li L; Zhang Q; Tan HM
Clin Exp Pharmacol Physiol; 2010 Nov; 37(11):1071-7. PubMed ID: 20698860
[TBL] [Abstract][Full Text] [Related]
34. Preclinical evaluation of saroglitazar magnesium, a dual PPAR-α/γ agonist for treatment of dyslipidemia and metabolic disorders.
Patel H; Giri P; Patel P; Singh S; Gupta L; Patel U; Modi N; Shah K; Jain MR; Srinivas NR; Patel P
Xenobiotica; 2018 Dec; 48(12):1268-1277. PubMed ID: 29224415
[TBL] [Abstract][Full Text] [Related]
35.
Osinski V; Bauknight DK; Dasa SSK; Harms MJ; Kroon T; Marshall MA; Garmey JC; Nguyen AT; Hartman J; Upadhye A; Srikakulapu P; Zhou A; O'Mahony G; Klibanov AL; Kelly KA; Boucher J; McNamara CA
Theranostics; 2020; 10(2):585-601. PubMed ID: 31903139
[TBL] [Abstract][Full Text] [Related]
36. Negative regulation of eNOS-NO signaling by over-SUMOylation of PPARγ contributes to insulin resistance and dysfunction of vascular endothelium in rats.
Yuan W; Ma C; Zhou Y; Wang M; Zeng G; Huang Q
Vascul Pharmacol; 2019; 122-123():106597. PubMed ID: 31479752
[TBL] [Abstract][Full Text] [Related]
37. Fish oil blunted nicotine-induced vascular endothelial abnormalities possibly via activation of PPARγ-eNOS-NO signals.
Taneja G; Mahadevan N; Balakumar P
Cardiovasc Toxicol; 2013 Jun; 13(2):110-22. PubMed ID: 23208382
[TBL] [Abstract][Full Text] [Related]
38. Decaffeinated green tea extract improves hypertension and insulin resistance in a rat model of metabolic syndrome.
Ihm SH; Jang SW; Kim OR; Chang K; Oak MH; Lee JO; Lim DY; Kim JH
Atherosclerosis; 2012 Oct; 224(2):377-83. PubMed ID: 22877868
[TBL] [Abstract][Full Text] [Related]
39. Wy14643 improves vascular function in the aorta of the spontaneously hypertensive rat mainly by activating peroxisome proliferator-activated receptors alpha.
Qu C; Leung SW; Vanhoutte PM; Man RY
Eur J Pharmacol; 2012 Dec; 696(1-3):101-10. PubMed ID: 23022336
[TBL] [Abstract][Full Text] [Related]
40. Saroglitazar for the treatment of dyslipidemia in diabetic patients.
Joshi SR
Expert Opin Pharmacother; 2015 Mar; 16(4):597-606. PubMed ID: 25674933
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
